Medical Prop SEC Filings

Williams Rosa Handley reported acquisition or exercise transactions in this Form 4 filing.

MEDICAL PROPERTIES TRUST INC reported that SVP of Operations Rosa Handley Williams received two equity awards of common stock totaling 63,750 shares on March 18, 2026. After these grants, she holds 452,774 shares directly.

One award of 42,500 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. The other 21,250-share award is performance-based and will be earned only if specific debt reduction and cash revenue growth targets set by the compensation committee are met over the period from January 1, 2026 through December 31, 2028. The actual number of performance shares ultimately issued will depend on achievement of these thresholds, including the opportunity to earn up to one third of the award for 2026 performance.

Medical Properties Trust Inc reported that SVP and Senior Advisor to the CEO Larry H. Portal acquired a total of 112,500 shares of common stock as equity awards. One grant of 75,000 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. A second award of 37,500 shares is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028 based on specific debt reduction and cash revenue growth thresholds set by the compensation committee, with the actual shares issued varying according to performance.

Medical Properties Trust Inc reported that SVP and Senior Advisor to the CEO Larry H. Portal acquired a total of 112,500 shares of common stock as equity awards. One grant of 75,000 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. A second award of 37,500 shares is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028 based on specific debt reduction and cash revenue growth thresholds set by the compensation committee, with the actual shares issued varying according to performance.

MEDICAL PROPERTIES TRUST INC senior vice president of finance and treasurer Charles R. Lambert reported stock-based compensation awards. He acquired 50,000 shares of common stock at no cost and then an additional 25,000 shares, bringing his direct holdings to 392,401 shares after the second grant.

The 50,000-share award vests in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. The 25,000-share award is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028, depending on specific thresholds for overall debt reduction and cash revenue growth set by the compensation committee, with up to one third tied to 2026 performance.

MEDICAL PROPERTIES TRUST INC senior vice president of finance and treasurer Charles R. Lambert reported stock-based compensation awards. He acquired 50,000 shares of common stock at no cost and then an additional 25,000 shares, bringing his direct holdings to 392,401 shares after the second grant.

The 50,000-share award vests in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. The 25,000-share award is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028, depending on specific thresholds for overall debt reduction and cash revenue growth set by the compensation committee, with up to one third tied to 2026 performance.

Medical Properties Trust, Inc. reported sharply improved results for 2025, moving from a large prior-year loss to a much smaller one while stabilizing its hospital real estate portfolio. Net income for the fourth quarter was $17 million, or $0.03 per share, compared with a net loss of $413 million, or $(0.69) per share, a year earlier. For the full year, the company recorded a net loss of $277 million, or $(0.46) per share, versus a $2.4 billion loss, or $(4.02) per share, in 2024, reflecting far lower impairment charges.

Normalized funds from operations, a key REIT cash-flow metric, were $106.6 million, or $0.18 per share, for the fourth quarter, essentially flat with the prior year, and $346.3 million, or $0.58 per share, for 2025, down from $482.7 million, or $0.80 per share, in 2024. The company highlighted progress repositioning challenged tenants, including new long-term leases and asset sales, and reiterated a goal of driving pro forma annualized cash rent from its current portfolio to at least $1 billion by the end of 2026.

MPT ended 2025 with total assets of $15.0 billion and debt, net of issuance costs and discounts, of $9.7 billion, resulting in financial leverage of 59.0% and an adjusted net debt to annualized EBITDAre ratio of 8.5x. The portfolio comprised 384 properties and approximately 39,000 licensed beds across nine countries, with general acute care hospitals representing the majority of assets and revenue.

Medical Properties Trust, Inc. reported sharply improved results for 2025, moving from a large prior-year loss to a much smaller one while stabilizing its hospital real estate portfolio. Net income for the fourth quarter was $17 million, or $0.03 per share, compared with a net loss of $413 million, or $(0.69) per share, a year earlier. For the full year, the company recorded a net loss of $277 million, or $(0.46) per share, versus a $2.4 billion loss, or $(4.02) per share, in 2024, reflecting far lower impairment charges.

Normalized funds from operations, a key REIT cash-flow metric, were $106.6 million, or $0.18 per share, for the fourth quarter, essentially flat with the prior year, and $346.3 million, or $0.58 per share, for 2025, down from $482.7 million, or $0.80 per share, in 2024. The company highlighted progress repositioning challenged tenants, including new long-term leases and asset sales, and reiterated a goal of driving pro forma annualized cash rent from its current portfolio to at least $1 billion by the end of 2026.

MPT ended 2025 with total assets of $15.0 billion and debt, net of issuance costs and discounts, of $9.7 billion, resulting in financial leverage of 59.0% and an adjusted net debt to annualized EBITDAre ratio of 8.5x. The portfolio comprised 384 properties and approximately 39,000 licensed beds across nine countries, with general acute care hospitals representing the majority of assets and revenue.

Medical Properties Trust, Inc. filed an 8-K to detail upcoming branding changes. The company’s New York Stock Exchange stock ticker will change from “MPW” to “MPT”, with trading under the new symbol beginning on February 2, 2026. Its common stock will remain listed on the NYSE and the CUSIP number will stay the same, so only the trading symbol is changing. The company also confirmed the previously planned relocation of its headquarters within Alabama to 10500 Liberty Parkway, Birmingham, Alabama 35242. These updates were announced in a press release furnished as an exhibit.

Medical Properties Trust director Emily Webster Murphy reported a new equity grant. On January 8, 2026, she was awarded 30,303 shares of common stock at a price of $0.00 per share, increasing her holdings to 105,828 shares held directly after the transaction.

The grant is subject to a vesting schedule. According to the filing, these shares vest in equal installments at the beginning of each of 12 calendar quarters, starting on April 1, 2026, meaning the award will vest over a three-year period if service conditions are met.

Medical Properties Trust director receives stock-based award. Director Stewart Michael G reported an award of 30,303 shares of Medical Properties Trust common stock on January 8, 2026, at a stated price of $0 per share, indicating this is an equity compensation grant rather than an open-market purchase.

After this grant, he beneficially owns 187,403 shares in total. According to the filing, these granted shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, creating a multi-year vesting schedule that ties the award to ongoing service with the company.

Medical Properties Trust director reports stock award

Director Thompson C. Reynolds III reported receiving 30,303 shares of Medical Properties Trust common stock on January 8, 2026. The reported price of $0 per share indicates this was an equity award rather than an open-market purchase. Following this grant, he beneficially owns 108,795 shares, held directly.

The award is structured to vest over time. According to the filing, the shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, aligning director compensation with the company’s longer-term performance.

Medical Properties Trust, Inc. director Steven G. Dawson reported receiving 30,303 shares of common stock on January 8, 2026. The shares were acquired at a price of $0, indicating they are an equity award rather than an open-market purchase. After this grant, Dawson directly holds 194,520 shares of common stock.

According to the filing, these 30,303 shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. In addition to his direct holdings, the report shows 10,000 shares held indirectly through his spouse's 401(k) and 13,138 shares held indirectly as trustee for the Dawson Interest Pension Plan.

Medical Properties Trust Inc. director Elizabeth N. Pitman reported acquiring 30,303 shares of the company’s common stock on January 8, 2026, at a price of $0 per share. These shares vest in equal installments at the beginning of each of the 12 calendar quarters starting April 1, 2026, meaning they will be earned gradually over three years. After this award, she beneficially owns 130,898 shares of Medical Properties Trust common stock held directly.